Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exemestane vs Tamoxifen in First-Line Metastatic Breast Cancer
NCT00002777Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- May 1996
- Primary completion
- Dec 2002
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of exemestane in breast cancer, sponsored by European Organisation for Research and Treatment of Cancer. Started May 1996; status: completed.
02
Drugs
exemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00002777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002777.